Compare TNGX & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNGX | ASTE |
|---|---|---|
| Founded | 2014 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2002 |
| Metric | TNGX | ASTE |
|---|---|---|
| Price | $12.31 | $63.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 199.0K |
| Earning Date | 04-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | N/A | ★ 784.21 |
| EPS | N/A | ★ 1.68 |
| Revenue | ★ $42,069,000.00 | N/A |
| Revenue This Year | $52.63 | $15.00 |
| Revenue Next Year | N/A | $4.13 |
| P/E Ratio | ★ N/A | $36.73 |
| Revenue Growth | ★ 15.17 | N/A |
| 52 Week Low | $1.04 | $29.65 |
| 52 Week High | $13.60 | $64.37 |
| Indicator | TNGX | ASTE |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 68.67 |
| Support Level | $11.00 | $44.05 |
| Resistance Level | $13.53 | N/A |
| Average True Range (ATR) | 0.77 | 2.83 |
| MACD | -0.16 | 0.16 |
| Stochastic Oscillator | 54.46 | 84.69 |
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.